| scholarly article | Q13442814 |
| P50 | author | Joerg Striessnig | Q51312605 |
| Nicolas Singewald | Q56872712 | ||
| P2093 | author name string | A Hetzenauer | |
| A Koschak | |||
| G Pelster | |||
| N K Nguyen | |||
| M J Sinnegger-Brauns | |||
| P Busquet | |||
| P433 | issue | Pt 5 | |
| P921 | main subject | voltage | Q25428 |
| P304 | page(s) | 903-909 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Biochemical Society Transactions | Q864226 |
| P1476 | title | Role of voltage-gated L-type Ca2+ channel isoforms for brain function | |
| P478 | volume | 34 |
| Q39519775 | 12-Lipoxygenase regulates hippocampal long-term potentiation by modulating L-type Ca2+ channels |
| Q33842208 | A folding pathway-dependent score to recognize membrane proteins |
| Q37471935 | A high-throughput fluorimetric microarray with enhanced fluorescence and suppressed "coffee-ring" effects for the detection of calcium ions in blood |
| Q35232631 | A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug. |
| Q38218083 | Advances in non-dopaminergic treatments for Parkinson's disease |
| Q47156445 | Alternative Splicing of L-type CaV1.2 Calcium Channels: Implications in Cardiovascular Diseases. |
| Q64298937 | Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness |
| Q89769130 | Association of the CACNA2D2 gene with schizophrenia in Chinese Han population |
| Q48086415 | CACNA1C SNP rs1006737 associates with bipolar I disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis |
| Q36323670 | CACNA1C risk variant affects facial emotion recognition in healthy individuals |
| Q64104574 | CACNA1C risk variant affects microstructural connectivity of the amygdala |
| Q64464812 | CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis |
| Q36908814 | Ca(2+) entry into neurons is facilitated by cooperative gating of clustered CaV1.3 channels |
| Q50668714 | Ca2+/calmodulin regulates trafficking of Ca(V)1.2 Ca2+ channels in cultured hippocampal neurons. |
| Q35034581 | CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model. |
| Q38945252 | Calcium and Parkinson's disease |
| Q42534539 | Calcium homeostasis in aging neurons |
| Q36798264 | Calcium homeostasis, selective vulnerability and Parkinson's disease |
| Q39141992 | Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission |
| Q36947731 | Calcium, ageing, and neuronal vulnerability in Parkinson's disease |
| Q37669479 | Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease |
| Q39204655 | Cav1.2 and Cav1.3 L-type calcium channels operate in a similar voltage range but show different coupling to Ca(2+)-dependent conductances in hippocampal neurons. |
| Q34006530 | Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area |
| Q45832169 | Cav1.3 calcium channels are required for normal development of the auditory brainstem |
| Q42705179 | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons |
| Q37705122 | Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels |
| Q39710652 | Common variants in CACNA1C and MDD susceptibility: A comprehensive meta-analysis. |
| Q36576250 | Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets |
| Q28074143 | Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease |
| Q48269597 | Correlation between oxidative stress and L-type calcium channel expression in the ventricular myocardia of selenium-deficient mice |
| Q55348364 | D-cis-Diltiazem Can Produce Oxidative Stress in Healthy Depolarized Rods In Vivo. |
| Q37081420 | Design of mutant beta2 subunits as decoy molecules to reduce the expression of functional Ca2+ channels in cardiac cells |
| Q28572387 | Direct interaction and functional coupling between voltage-gated CaV1.3 Ca2+ channel and GABAB receptor subunit 2 |
| Q39631171 | Do Copy Number Changes in CACNA2D2, CACNA2D3, and CACNA1D Constitute a Predisposing Risk Factor for Alzheimer's Disease? |
| Q44490894 | Effects of a CACNA1C genotype on attention networks in healthy individuals |
| Q35147824 | Ethanol alters calcium signaling in axonal growth cones |
| Q50868810 | G protein modulation of K2P potassium channel TASK-2 : a role of basic residues in the C terminus domain. |
| Q40676388 | Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta-analysis |
| Q43007346 | Homeostatic switch in hebbian plasticity and fear learning after sustained loss of Cav1.2 calcium channels. |
| Q37819813 | Impact of gating modulation in CaV1.3 L-type calcium channels |
| Q41205004 | Impaired Fear Extinction Due to a Deficit in Ca2+ Influx Through L-Type Voltage-Gated Ca2+ Channels in Mice Deficient for Tenascin-C. |
| Q24632514 | Inhibition of recombinant L-type voltage-gated calcium channels by positive allosteric modulators of GABAA receptors |
| Q37180671 | Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons |
| Q47609382 | Investigating the role of nisoldipine in foot-shock-induced post-traumatic stress disorder in mice. |
| Q38703042 | Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice |
| Q48911406 | L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats |
| Q41529612 | L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse model |
| Q36337465 | Levels of Ca(V)1.2 L-Type Ca(2+) Channels Peak in the First Two Weeks in Rat Hippocampus Whereas Ca(V)1.3 Channels Steadily Increase through Development |
| Q37795701 | L‐type calcium channels and psychiatric disorders: A brief review |
| Q58785403 | Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells |
| Q58693945 | Mitochondrial dysfunction in Parkinson's disease |
| Q42439672 | Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429. |
| Q38454157 | Neurodegeneration in the elderly - When the blood type matters: An overview of the McLeod syndrome with focus on hematological features |
| Q46704914 | Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels |
| Q23916365 | Neurotoxicity following acute inhalation exposure to the oil dispersant COREXIT EC9500A |
| Q35578795 | Neutralization of a single arginine residue gates open a two-pore domain, alkali-activated K+ channel |
| Q38974102 | Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses |
| Q27006437 | Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders |
| Q39613169 | Pregabalin antagonizes copper-induced toxicity in the brain: in vitro and in vivo studies |
| Q35728647 | RNA editing of the IQ domain in Ca(v)1.3 channels modulates their Ca²⁺-dependent inactivation. |
| Q42536330 | Raised activity of L-type calcium channels renders neurons prone to form paroxysmal depolarization shifts. |
| Q38888524 | Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection |
| Q48584356 | Regulation and the Mechanism of Estrogen on Cav1.2 Gene in Rat-Cultured Cortical Astrocytes. |
| Q46241560 | Repertoire of high voltage-activated Ca2+ channels in the lateral superior olive: functional analysis in wild-type, Ca(v)1.3(-/-), and Ca(v)1.2DHP(-/-) mice |
| Q47700226 | Role of CACNA1C gene polymorphisms and protein expressions in the pathogenesis of schizophrenia: a case-control study in a Chinese population |
| Q30489951 | Selective and protracted effect of nifedipine on fear memory extinction correlates with induced stress response |
| Q26749433 | Sleep Spindles as Facilitators of Memory Formation and Learning |
| Q34979269 | Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channels |
| Q37322293 | Supramolecular assemblies and localized regulation of voltage-gated ion channels. |
| Q38260270 | TASK-2 K₂p K⁺ channel: thoughts about gating and its fitness to physiological function |
| Q36799584 | Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers |
| Q37780206 | The origins of oxidant stress in Parkinson's disease and therapeutic strategies. |
| Q39281423 | The role of Ca2+ signaling in Parkinson's disease |
| Q28243321 | The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function |
| Q35628604 | The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease |
| Q90666605 | The voltage-gated calcium channel CaV1.2 promotes adult oligodendrocyte progenitor cell survival in the mouse corpus callosum but not motor cortex |
| Q41903612 | Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions. |
| Q35799141 | Toxin models of mitochondrial dysfunction in Parkinson's disease. |
| Q47578142 | Type-1 astrocyte-like stem cells harboring Cacna1d gene deletion exhibit reduced proliferation and decreased neuronal fate choice. |
| Q37809751 | Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease |
| Q37363926 | What causes cell death in Parkinson's disease? |
| Q42942424 | What causes the death of dopaminergic neurons in Parkinson's disease? |
| Q37356891 | Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease |
| Q37010156 | p38 mitogen-activated protein kinase and calcium channels mediate signaling in depolarization-induced activation of peroxisome proliferator-activated receptor gamma coactivator-1alpha in neurons |
Search more.